Professor Lily Yao, Professor in Health Economics, specialises in economic evaluations alongside large clinical trials and decision-analytic models, particularly in health technology assessment. She has successfully led on the economic components for more than 30 largescale studies, including commissions from the National Institute of Clinical Excellence (NICE).
Professor Yao’s research interests include economic evaluation in public health. She is currently conducting several research projects in public health including projects to address antibiotic resistance in China, mental health as well as multi-morbidity and public health policies in COVID-19.
Professor Yao is working in collaboration with academics at Beijing Normal University to conduct modelling of population migration, disease spread and the effect of interventions in China. She is also part of a group of public health experts and academics calling for the public to wear face coverings in public places to reduce the spread of the COVID-19 virus.
Sam Tromans, Guiqing Yao, Reza Kiani, Regi Alexander, Mohammed Al-Uzri, Traolach Brugha. An investigation of the prevalence of autism among adults admitted to acute mental health wards: A cross-sectional study. accepted for publication in BMJ open.
Letouze D, Yao G, Clarke SC. The costs associated with the public health management of a cluster of meningococcal infection in England. Vaccine. 2014 Sep 29;32(43):5549-51. doi: 10.1016/j.vaccine.2014.08.044. Epub 2014 Aug 27. PMID: 25173479
Wu J., Zhu S., Yao G., Mohammed M.A., Marshall T. Patient Factors Influencing the Prescribing of Lipid Lowering Drugs for Primary Prevention in UK General Practice: A National Retrospective Cohort Study. PLOT PLoS One. 2013 Jul 26;8(7):e67611.
Yao G., Novielli N., Manaseki-Holland S., Chen Y., van der Klink M., Lilford R.J.. Pre-development evaluation of service delivery interventions: an application to an intervention to improve clinical handover. BMJ Qual Saf. 2012 Dec;21 Suppl 1:i29-38
Zhu, Shihua, Song, Fujian, Lilford, Richard, Bayliss, Sue, Chilton, Peter, Cummins, Carole, Duffy, John and Yao, GuiqingLily (2012) Ambu aScope2 in unexpected difficult airways management. External Assessment Report Birmingham, GB NICE 140pp. https://www.nice.org.uk/guidance/mtg14/resources/ambu-ascope2-for-use-in-unexpected-difficult-airways-eac-assessment-report2
Yao G., Freemantle N., Marcus F.,Tharmanathan P., Coats A. and Poole-Wilson P.A.. Long-Term Cost-effectiveness Analysis of Nebivolol Compared With Placebo In Elderly Patients With Heart Failure – An Individual Patient based Simulation Model – Pharmacoeconomics. 2008;26(10):879-889.
Yao G., Freemantle N., Calvert M. J., Bryan S., Claude, Daubert. Cleland J.G.F. The Long-term Cost-Effectiveness of Cardiac Resynchronization Therapy with or Without an Implantable Cardioverter-Defibrillator. European Heart Journal 2007 28: 42-51.
Miners A., Yao G., Raftery J, Taylor R.. Calcineurin Inhibitors in Renal Transplantation: A Review of Their Cost Effectiveness. Pharmacoeconomics. 2007;25(11):935-47
Wilson J, Yao GL, Raftery J, Bohlius J, Brunskill S, Sandercock J, Bayliss S, Moss P, Stanworth S, Hyde C. A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment. Health Technol Assess. 2007 Apr;11(13):1-202, iii-iv. Review.
Yao G., Albon E., Adi, Y, Milford D., Bayliss S., Ready A., Raftery J., and Taylor R.. A systematic review and economic model of the clinical and cost-effectiveness of immunosuppressive therapy for renal transplantation in children.. Health Technology Assessment. 2006 Dec;10 (49):1-178.